Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongyi Li

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cancer Science|August 8, 2015
Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcomaXuan Jiang, Jinlu Shan, Nan Dai, et al.
Scientific Reports|December 15, 2015
Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based ChemotherapyYu Peng, Linang Wang, Yi Qing, et al.
Drug Design, Development and Therapy|April 8, 2015
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinomaChongyi Li, Yanli Xiong, Xueqin Yang, et al.
Oncotarget|June 8, 2018
miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonucleaseNan Dai, Yi Qing, Yanping Cun, et al.
Drug Design, Development and Therapy|December 31, 2014
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathwayTao Ren, Jinlu Shan, Yi Qing, et al.
Drug Design, Development and Therapy|June 20, 2015
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancerTao Ren, Jinlu Shan, Mengxia Li, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cancer Science|August 8, 2015
Apurinic/apyrimidinic endonuclease 1 regulates angiogenesis in a transforming growth factor β-dependent manner in human osteosarcomaXuan Jiang, Jinlu Shan, Nan Dai, et al.
Scientific Reports|December 15, 2015
Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based ChemotherapyYu Peng, Linang Wang, Yi Qing, et al.
Drug Design, Development and Therapy|April 8, 2015
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinomaChongyi Li, Yanli Xiong, Xueqin Yang, et al.
Oncotarget|June 8, 2018
miR-513a-5p regulates radiosensitivity of osteosarcoma by targeting human apurinic/apyrimidinic endonucleaseNan Dai, Yi Qing, Yanping Cun, et al.
Drug Design, Development and Therapy|December 31, 2014
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathwayTao Ren, Jinlu Shan, Yi Qing, et al.
Drug Design, Development and Therapy|June 20, 2015
Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancerTao Ren, Jinlu Shan, Mengxia Li, et al.
Pageof 6